NPI: 1861949331 · TEMECULA, CA 92592 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/01/2016
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/01/2016 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 1,726 | $116K |
| 2021 | 2,663 | $189K |
| 2022 | 6,470 | $179K |
| 2023 | 9,144 | $333K |
| 2024 | 5,542 | $432K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 11,277 | 1,000 | $1.20M |
| J1756 | Injection, iron sucrose, 1 mg | 2,420 | 584 | $25K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 317 | 181 | $16K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,457 | 538 | $4K |
| 83970 | 248 | 238 | $4K | |
| A4657 | Syringe, with or without needle, each | 1,045 | 420 | $3K |
| 82728 | 112 | 103 | $375.50 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 41 | 39 | $363.30 |
| 0250 | 719 | 39 | $282.54 | |
| 85041 | 335 | 294 | $244.22 | |
| 85048 | 277 | 246 | $206.72 | |
| 83540 | 101 | 92 | $177.94 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 134 | 12 | $0.00 |
| 83550 | 42 | 40 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 20 | 12 | $0.00 |